NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-038-2018-0-US-03 Human Antibodies Against ROR1 US ORD 16/179,364 10428141 Issued PDF
NIAID E-099-2016-1-PCT-02 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS PCT PCT PCT/US2018/059073 Expired
NIDCR E-485-2013-1-PCT-02 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS PCT PCT PCT/US2018/058887 Expired
NIAID E-099-2016-1-CN-11 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CN National Stage 2018800979422 Issued
NIAID E-099-2016-1-EP-13 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS EP National Stage 18927570.4 Abandoned
NCI E-038-2018-0-EP-09 Human Antibodies Against ROR1 EP National Stage 18871951.2 Pending
NIAID E-099-2016-1-CA-09 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CA National Stage 3106976 Abandoned
NCI E-038-2018-0-CA-06 Human Antibodies Against ROR1 CA National Stage 3081719 Pending
NIAID E-099-2016-1-CL-10 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CL National Stage 202100176 Issued
NCI E-038-2018-0-CN-08 Human Antibodies Against ROR1 CN National Stage 201880078376.0 Pending
NIAID E-099-2016-1-KR-18 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS KR National Stage 10-2021-7004418 Issued
NIAID E-099-2016-1-SG-21 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS SG National Stage 11202100709X Issued
NIAID E-099-2016-1-ZA-22 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS ZA National Stage 2021/00466 Issued
NIAID E-099-2016-1-MX-19 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS MX National Stage MX/a/2021/000868 Issued
NIAID E-099-2016-1-JP-17 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS JP National Stage 2021-502958 Abandoned
NCI E-038-2018-0-AU-05 Human Antibodies Against ROR1 AU National Stage 2018360031 Pending
NIAID E-099-2016-1-BR-08 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS BR National Stage BR112021001206-0 Issued
NIAID E-099-2016-1-AU-07 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS AU National Stage 2018433819 Abandoned
NCI E-038-2018-0-PCT-02 Human Antibodies Against ROR1 PCT PCT PCT/US2018/059003 Expired
NIAID E-099-2016-1-EA-12 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS EA National Stage 202190171 Issued
NIAID E-099-2016-1-GB-14 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS GB National Stage 2100942.8 Abandoned
NIAID E-099-2016-1-IN-16 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS IN National Stage 202117004165 Issued
NIAID E-099-2016-1-IL-15 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS IL National Stage 2024-02-28 Abandoned
NCI E-077-2008-0-US-04 IMMUNOGENIC COMPOSITIONS COMPRISING A PAPILLOMA VIRAL CAPSID US DIV 16/178,834 Abandoned
NHLBI E-121-2016-2-IL-06 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE IL National Stage 273979 Issued
NHLBI E-121-2016-2-CN-03 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE CN National Stage 201880071474.1 Issued
NHLBI E-121-2016-1-CN-02 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE CN National Stage 201780046354.1 Issued
NHLBI E-121-2016-2-JP-07 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE JP National Stage 2020-524196 Issued
NIAID E-145-2015-3-US-04 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 16/178,277 10413527 Issued PDF
NHLBI E-121-2016-2-PCT-02 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE PCT PCT PCT/US2018/058747 Expired
NHLBI E-121-2016-2-HK-05 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE HK National Stage 62020017347.9 Pending
NHLBI E-121-2016-2-EP-04 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE EP National Stage 18811415.1 Pending
NHLBI E-121-2016-2-SG-08 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE SG National Stage 11202003201Q Pending
NHGRI E-148-2017-0-PCT-02 ISOTOPIC BIOMARKERS OF ORGANIC ACIDEMIAS PCT PCT PCT/US2018/058515 Expired
NIBIB E-149-2016-0-US-03 Albumin-binding Immunodulatory Compositions And Methods Of Use Thereof US National Stage 16/098,115 Abandoned
NHGRI E-148-2017-0-EP-03 ISOTOPIC BIOMARKERS OF ORGANIC ACIDEMIAS EP National Stage 18807166.6 Abandoned
NHGRI E-034-2019-0-RU-12 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA RU National Stage 2021105822 Abandoned
NCATS E-101-2017-0-EP-03 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS EP National Stage 18804792.2 Issued
NCATS E-101-2017-0-GB-01 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS GB EP 18804792.2 Issued
NCATS E-101-2017-0-DE-01 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS DE EP 18804792.2 Issued
NCATS E-101-2017-0-FR-01 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS FR EP 18804792.2 Issued
NHLBI E-156-2016-0-AU-03 ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS AU National Stage 2017261249 Issued
NHLBI E-186-2014-1-US-08 METHOD OF TREATING GRAFT VERSUS HOST DISEASE WITH AN INTERLEUKIN-2 MUTEIN US DIV 16/175,709 10654905 Issued PDF
NHGRI E-034-2019-0-PCT-02 Targeted Integration Into The Albumin (Alb) Locus As A Treatment For Hereditary Methylmalonic Acidemia (MMA) Caused By Methylmalonyl-coA Mutase (MUT) Deficiency PCT PCT PCT/US2018/058307 Expired
NCATS E-101-2017-0-PCT-02 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS PCT PCT PCT/US2018/058257 Expired
NLM E-107-2010-2-US-24 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/175,353 Abandoned
NHGRI E-034-2019-0-CN-13 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA CN National Stage 201880098490.X Pending
NHGRI E-034-2019-0-EP-03 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA EP National Stage 18929532.2 Pending
NHGRI E-034-2019-0-IN-14 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA IN National Stage 202117007847 Abandoned
NHGRI E-034-2019-0-JP-09 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA JP National Stage 2021-531445 Pending